pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,210 catalysts · 7,208 phase readout · 2,441 8k filing · 386 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: approval×type: phase readout×clear all
type
  • phase readout7,208
  • 8k filing2,441
  • earnings386
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07460232: FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Sponsor: Mayo Clinic. Phase: EARLY_PHASE1. Conditions: Cushing Disease, Pituitary Adenoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05835999: Everolimus Aging Study

Sponsor: University of Wisconsin, Madison. Phase: PHASE2. Conditions: Aging, Insulin Resistance

full page →ctgov ↗
›COMPLETEDphase readoutNCT07624032: PNF Versus Cryotherapy in Delayed Onset Muscle Soreness

Sponsor: Universidad Pontificia de Salamanca. Phase: NA. Conditions: Delayed Onset Muscle Soreness (DOMS)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06321432: Intensive Weight Loss Intervention Versus Usual Care for Adults With Obesity

Sponsor: Carsten Dirksen. Phase: NA. Conditions: Obesity

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07487493: The Effect of Technology-Based Education Given to Mothers During the Transition to Complementary Feeding on Infant Development, Transition to Complementary Feeding Behavior, and Mothers' Anxiety Levels

Sponsor: Saglik Bilimleri Universitesi Gulhane Tip Fakultesi. Phase: NA. Conditions: Complementary Feeding, Pediatric Nurse

full page →ctgov ↗
›RECRUITINGphase readoutNCT07327593: Exercise Induced Hypoalgesia in Pain-free Stroke and Healthy Populations: a Cohort Study

Sponsor: Neuron, Spain. Phase: NA. Conditions: Stroke, Pain, Exercise Induced Hypoalgesia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06310187: Little Cigar Oxidants

Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Tobacco Use, Oxidative Stress

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07727187: Hepatitis B Infection Surveillance

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Chronic Hepatitis B Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07719621: Evaluation of the Risk of Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Sponsor: Aeterna Medical Solutions SL. Phase: . Conditions: CKD - Chronic Kidney Disease, Diabetes Mellitus Type 2

full page →ctgov ↗
›RECRUITINGphase readoutNCT05958121: IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors

Sponsor: Immatics Biotechnologies GmbH. Phase: PHASE1. Conditions: Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07678216: Comparing Sedatives for Intracranial Pressure Control in Traumatic Brain Injury

Sponsor: Aswan University. Phase: NA. Conditions: Moderate-to-Severe Traumatic Brain Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT07393906: Colorectal Cancer Prevention Research Study: Eat Right, Screen Right

Sponsor: University of Florida. Phase: NA. Conditions: Colorectal Cancer Prevention

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07399106: Enhancing Child and Adolescent Mental Health Service Referrals 2

Sponsor: Greater Manchester Mental Health NHS Foundation Trust. Phase: . Conditions: No Conditions, Improving Referrals Into NHS CAMHS

full page →ctgov ↗
›RECRUITINGphase readoutNCT07613606: Injectable Platelet-Rich Fibrin With Minimally Invasive Non-Surgical Technique in Treatment of Periodontal Intrabony Defects

Sponsor: October 6 University. Phase: NA. Conditions: Platelet-Rich Fibrin, Minimally Invasive Non-Surgical Technique, Periodontal Intrabony Defects

full page →ctgov ↗
›TERMINATEDphase readoutNCT03066206: Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Non-Small Cell Lung Cancer AJCC v7

full page →ctgov ↗
›COMPLETEDphase readoutNCT06522906: Mobilizing Hispanics With Knee Osteoarthritis

Sponsor: University of Arizona. Phase: NA. Conditions: Osteoarthritis, Knee

full page →ctgov ↗
›RECRUITINGphase readoutNCT06994806: A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Sponsor: Kumquat Biosciences Inc.. Phase: PHASE1. Conditions: Solid Tumor Malignancies

full page →ctgov ↗
›RECRUITINGphase readoutNCT07040904: Mindfulness to Enhance Cognitive Health in Latino Older Adults

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Mindfulness, Alzheimer's Disease Related Dementia

full page →ctgov ↗
›RECRUITINGphase readoutNCT05668884: GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma

Sponsor: Fudan University. Phase: PHASE2. Conditions: Biliary Tract Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07604584: Effects of Platelet-Rich Fibrin After Mandibular Third Molar Surgery in Smokers and Nonsmokers

Sponsor: Ankara University. Phase: NA. Conditions: Impacted Mandibular Third Molar, Postoperative Pain, Trismus, Facial Swelling

full page →ctgov ↗
›COMPLETEDphase readoutNCT04287049: A Study of Standard Drugs for Mycobacterium Avium Complex

Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Mycobacterium Avium Complex

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07564349: Comparison of 7-Day ECG Patches

Sponsor: Medical University Innsbruck. Phase: NA. Conditions: Atrial Fibrillation (AF), Cardiac Arrhythmias

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07583238: Diathermy On Diabetes Glucose Monitoring Effectiveness

Sponsor: University of Nottingham. Phase: . Conditions: Type 1 Diabetes Mellitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07454564: Preoperative Cardiac Power Output and P-POSSUM Score

Sponsor: Necmettin Erbakan University. Phase: . Conditions: Surgical Risk Assessment, Postoperative Mortality, Postoperative Morbidity

full page →ctgov ↗
›COMPLETEDphase readoutNCT04577898: RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows

Sponsor: Teoxane SA. Phase: NA. Conditions: Infra-orbital Hollows, Tear-trough Deformity, Wrinkle

full page →ctgov ↗
›RECRUITINGphase readoutNCT07067398: Improving the Heart Health of Home Health Aides

Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Cardiovascular, Cardiovascular (CV) Risk, Cardiovascular Disease (CVD) Risk Factors, Cardiovascular Health

full page →ctgov ↗
›RECRUITINGphase readoutNCT05702398: Pilot Trial of Supplemental Vitamin A and Nicotinamide

Sponsor: Rhode Island Hospital. Phase: EARLY_PHASE1. Conditions: Skin Cancer, Kidney Transplant Recipients

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03756298: Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Sponsor: National Cancer Center, Korea. Phase: PHASE2. Conditions: Triple Negative Breast Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06660498: Pomalidomide as an Immune-enhancing Agent for the Control of HIV

Sponsor: University of Aarhus. Phase: PHASE1. Conditions: HIV-1 Infection

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04603898: Oxalate Formation From Ascorbic Acid

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Kidney Stone

full page →ctgov ↗
›RECRUITINGphase readoutNCT07267598: Suitability of a 26 °C Indoor Environment for Mitigating Heat Strain in Young Adults

Sponsor: University of Ottawa. Phase: NA. Conditions: Heat Stress, Physiological Stress, Cognitive Change

full page →ctgov ↗
›RECRUITINGphase readoutNCT06847763: The Long Term Effects of Online Therapeutic Neuroscience Education in Patients With Chronic Low Back Pain

Sponsor: Istanbul Bilgi University. Phase: NA. Conditions: Low Back Pain, Mechanical, Chronic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07734363: Role of Craving in the Transition Across Level of Addiction Severity: A Longitudinal Study.

Sponsor: University of Bordeaux. Phase: . Conditions: Addiction

full page →ctgov ↗
›SUSPENDEDphase readoutNCT05378763: A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations

Sponsor: Spectrum Pharmaceuticals, Inc. Phase: PHASE3. Conditions: NSCLC

full page →ctgov ↗
›RECRUITINGphase readoutNCT05495087: IHT for Mild Cognitive Impairment

Sponsor: University of North Texas Health Science Center. Phase: NA. Conditions: Mild Cognitive Impairment, Memory Impairment

full page →ctgov ↗
›RECRUITINGphase readoutNCT05908487: African Americans (AA) Communities Speak

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Healthy Aging, Health Knowledge, Attitudes, Practice, Social Responsibility, Care Eliciting Behavior, Racism, Systemic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07450287: CardioNETPOL National Registry of Carcinoid Heart Disease

Sponsor: National Institute of Cardiology, Warsaw, Poland. Phase: . Conditions: Carcinoid Heart Disease, Neuroendocrine Tumors, Carcinoid Syndrome, Valvular Heart Disease Patients

full page →ctgov ↗
›RECRUITINGphase readoutNCT07292987: Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital

Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts. Phase: NA. Conditions: Retinitis Pigmentosa (RP)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07192614: A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06894914: Supporting Uptake of Evidence for Physical Activity in Older Adults With Complex Health Care Needs

Sponsor: University of British Columbia. Phase: NA. Conditions: Frailty

full page →ctgov ↗
›RECRUITINGphase readoutNCT06598306: Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Sponsor: Amgen. Phase: PHASE1. Conditions: Extensive Stage Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT04483206: Personalized Autologous Transplant for Multiple Myeloma

Sponsor: Emory University. Phase: PHASE1. Conditions: Multiple Myeloma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05518084: Safety of Cell-free Adipose Tissue Product in Healthy Volunteers

Sponsor: Linio Biotech Oy. Phase: NA. Conditions: Safety Issues

full page →ctgov ↗
›RECRUITINGphase readoutNCT06105684: Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer

Sponsor: University of Alabama at Birmingham. Phase: PHASE2. Conditions: Metastatic Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07761052: The Latino Youth and Family Empowerment Study - III (LYFE-III): Bringing to Scale a Culturally-Adapted and Evidence-Based Intervention for Latino Families

Sponsor: Texas A&M University. Phase: NA. Conditions: Control Condition, Parent

full page →ctgov ↗
›RECRUITINGphase readoutNCT07612852: Digital Engagement for Lifelong Health

Sponsor: Istituto per la Ricerca e l'Innovazione Biomedica. Phase: NA. Conditions: Life Style, Healthy, Risk Reduction, Health Promotion

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT03135847: Prosthetic Limb Movement Feedback for Upper and Lower Extremity Amputees

Sponsor: The Cleveland Clinic. Phase: NA. Conditions: Prosthesis User, Amputation

full page →ctgov ↗
›COMPLETEDphase readoutNCT07293949: Ultrasonographic Evaluation of Talar Cartilage Thickness in Patients With Spinal Cord Injury

Sponsor: Gaziosmanpasa Research and Education Hospital. Phase: . Conditions: Spinal Cord Injuries (SCI), Osteoarthritis (OA)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07789938: Intraoperative Neurophysiological Monitoring in Brain Tumor Surgery: Prospective Cohort Studies

Sponsor: Odense University Hospital. Phase: NA. Conditions: Intraoperative Neurophysiological Monitoring, Malignant Brain Tumors, Motor Evoked Potential Monitoring, Cortico-cortical Evoked Potential Monitoring, Visual Evoked Potential Monitoring

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07789158: Induction Chemotherapy Response-Guided Reduced-Dose Radiotherapy for Nasopharyngeal Carcinoma

Sponsor: Fudan University. Phase: PHASE2. Conditions: Nasopharyngeal Carcinoma (NPC)

full page →ctgov ↗
← prev
page 141 of 145
next →